ArticleThe Biochemical journal2023

ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1.

Kathryn Balmanno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.